This kit uses PCR+CE methods to detect nine mononucleotide repeat sites including BAT25, BAT26, NR21, NR24, MONO27, BAT52, BAT56, BAT59, and BAT60 in tumor tissues to guide the diagnosis of colorectal cancer patients, especially treated with immune c

The c-MET exon 14 skipping mutation exists in a variety of solid tumors, mainly in non-small cell lung cancer (NSCLC). The mutation rate in lung adenocarcinoma is about 3%, and the mutation rate in lung squamous cell carcinoma is about 2%, especially

c-MET is a proto-oncogene that encodes a transmembrane receptor for Hepatocyte Growth Factor (HGF) and has Tyrosine Kinase (TKs) activity. Abnormal c-MET is related to the occurrence and development of various tumors. The detection of abnormal c-MET

The transmembrane receptor-like protein encoded by the proto-oncogene Human Epidermal Growth Factor Receptor 2 (HER2) gene has tyrosine kinase activity, and HER2 is an important prognostic factor for breast cancer. Breast cancer with HER2 gene amplif

Prostate cancer is one of the most common malignant tumors of the urinary system. Androgen receptor (AR) plays an important role in the occurrence and development of prostate cancer. It promotes the progression and metastasis of prostate cancer by re

MPN is a group of clonal hematopoietic stem cell diseases characterized by the continuous proliferation of one or more myeloid lineages in the bone marrow. The WHO 2016 classification of MPN includes seven sub-types, among which PV, ET and PMF are co